
Cocrystal Pharma COCP
€ 1.19
-1.06%
Geschäftsbericht 2025
hinzugefügt 31.03.2026
Cocrystal Pharma P/E 2011-2026 | COCP
P/E Jährlich Cocrystal Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.29 | -0.825 | -0.751 | -0.388 | -0.291 | -9.84 | -0.364 | -1.64 | -197 | -3.67 | -7.67 | -1.49 K | -2.18 | -29.2 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.291 | -1.49 K | -124 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-2.15 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.0355 | $ 0.81 | -3.11 % | $ 37 M | ||
|
Exelixis
EXEL
|
15 | $ 46.21 | -5.11 % | $ 12.5 B | ||
|
Athira Pharma
ATHA
|
-0.0167 | - | - | $ 269 M | ||
|
Fortress Biotech
FBIO
|
11.4 | $ 2.43 | -4.71 % | $ 67.8 M | ||
|
Heron Therapeutics
HRTX
|
-9.82 | $ 1.24 | -5.73 % | $ 207 M | ||
|
InflaRx N.V.
IFRX
|
-1.39 | $ 2.86 | 14.2 % | $ 192 M | ||
|
Ionis Pharmaceuticals
IONS
|
-56.3 | $ 75.53 | -1.72 % | $ 12.1 B | ||
|
BioNTech SE
BNTX
|
6.11 | $ 92.4 | -3.0 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Kymera Therapeutics
KYMR
|
-25.5 | $ 85.56 | -0.81 % | $ 7.23 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-551 | $ 212.11 | -8.79 % | $ 3.88 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
14.1 | $ 22.02 | 2.51 % | $ 3.65 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-233 | $ 100.27 | -8.92 % | $ 5.03 B | ||
|
MannKind Corporation
MNKD
|
169 | $ 3.59 | 0.7 % | $ 1.1 B | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
-24.7 | $ 3.15 | - | $ 655 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 3.65 | 8.96 % | $ 6.01 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Genprex
GNPX
|
-0.102 | $ 0.88 | -1.48 % | $ 821 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Matinas BioPharma Holdings
MTNB
|
-0.265 | $ 0.65 | -4.03 % | $ 3.56 M | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Nanobiotix S.A.
NBTX
|
-5.57 K | $ 43.46 | 3.82 % | $ 286 B | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 21.33 | -11.75 % | $ 2.71 B | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Genmab A/S
GMAB
|
33.2 | $ 27.16 | -2.62 % | $ 16.8 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M |